Introduction
G-protein coupled receptors (GPCRs) are expressed throughout the nervous system and influence systems important for homeostasis. The canonical G-protein signaling pathways consists of a ligand binding to the receptor, exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) on the heterotrimeric G-protein α-subunit (Gα), separation of the Gβγ dimer (Gβγ) from the Gα subunit, and modulation of divergent downstream effector proteins by Gα-GTP and Gβγ. For example, free Gβγ can associate with N-type voltage-gated Ca 2+ channels to reduce the probability of channel opening upon membrane depolarization. The strength and duration of this interaction will be influenced by competition with proteins possessing a high affinity for Gβγ including Gα-GDP. Therefore, the duration of G-protein signaling is dependent upon the GTP hydrolysis rate since coalescence of the Gαβγ heterotrimer terminates signaling. Other proteins that bind Gβγ with high affinity, such as the carboxylterminus of GRK2 (ctGRK2) or phospholipase C-β2, attenuate Gβγ signaling (Ford et al., 1998 ).
Here we examined how the expression of phosducins, a protein family known to interact with Gβγ, influenced GPCR-mediated N-type Ca 2+ channel modulation in sympathetic neurons. The goals of the study were to: 1) characterize the effects of PDC and PDCL expression within the context of protein-based optical sensor development, and 2) provide insight into possible physiological roles for PDC/PDCL modification of GPCR responses in neurons.
Phosducin (PDC) is a 28 kDa soluble protein expressed primarily in the retina and pineal gland (Schulz, 2001; Sokolov et al., 2004) . Retinal PDC has been hypothesized to adjust the gain of luminosity perception in the vertebrate eye (Thulin et al., 2001 ) by sequestering transducin Gβγ (Gβ 1 γ 1 ) from the rod outer segment plasma membrane following rhodopsin activation. PDC binds with high affinity to Gβ 1 γ 1 as well as several other Gβγ combinations (Lee et al., 1987;  This article has not been copyedited and formatted. The final version may differ from this version. Müller et al., 1996) . The crystal structure of the PDC/Gβ 1 γ 1 complex reveals that the N-terminus of PDC contains three α-helices while the C-terminal portion is comprised of β-sheets with overall homology to bacterial thioredoxin (Gaudet et al., 1996 (Gaudet et al., , 1999 Loew et al., 1996) . The Nterminal domain of PDC contacts regions of Gβ common to the interface between Gα and Gβγ in the heterotrimer. Thus, binding of PDC to Gβγ occludes re-association of Gβγ with the Gα subunit (Xu et al., 1995) . Structural analyses also indicate that PDC induces a conformational change in Gβγ that buries the isoprenyl group of Gγ within the seven-bladed β-propeller structure of Gβ thereby decreasing the affinity of Gβγ for the lipid bilayer (Lukov et al., 2004) .
A homolog of PDC, phosducin-like protein (PDCL), was discovered during a screen for ethanol responsive genes (Miles et al., 1993) . Although less is known about its cellular functions, PDCL exhibits a more ubiquitous expression pattern (Schroder and Lohse, 2000) , binds Gβγ with high affinity, and potentially regulates G-protein receptor function (Schroder et al., 1996; Shultz et al., 1998) . The N-terminal domain of PDCL is alternatively spliced and larger than the N-terminal domain of PDC. At present, high-resolution structures of PDCL in complex with Gβγ are unavailable although biochemical studies indicate that heterologously expressed PDCL acts similarly to PDC by binding to and solubilizing Gβγ (Lukov et al., 2004; Thibault et al., 1997) .
MOL 21394
6 (Hu and Kerpolla, 2003) are amenable to high throughput detection and rely on the dynamic interaction of distinct sensor components. An assay based on these techniques could benefit from the bipartite structure of these Gβγ binding proteins. For example, knowledge of the crystal structure of the PDC-Gβγ complex makes conformational optimization via techniques such as circular permutation possible. Additionally, changes in binding affinity with phosphorylation (Gaudet et al., 1999; Thulin et al., 2001; Humrich et al., 2003) , and promiscuity in Gβγ binding (Müller et al., 1996) may provide a means of producing a tunable and universal detector of free Gβγ following receptor stimulation.
In this report we show that heterologous expression of PDC or PDCL in rat superior cervical ganglia (SCG) neurons attenuates GPCR-mediated voltage-dependent inhibition of N- The solution was adjusted to pH 7.4 with methanesulphonic acid and had an osmolality of 325-330 mosm/kg. The bathing solution was supplemented with 100 nM tetrodotoxin, to block endogenous voltage-gated Na + channels. Series resistance prior to electronic compensation (typically 80%) ranged from 2-6 MΩ. During recordings, neurons were continuously superfused with external solution. G-protein coupled receptors were activated by releasing external solution containing agonist over the cell surface using a gravity driven perfusion system positioned approximately 50 µm from the soma. Drug delivery was controlled electronically via solenoid valves driven by software commands. Currents were low-pass filtered at 5 kHz, digitized at a frequency of 10 kHz, and stored on a Macintosh G4 computer using custom developed software.
Data were analyzed using the Igor Pro software package (Wavemetrics, Lake Oswego, OR).
L-glutamic acid, ± norepinephrine HCl, and guanylyl imidophosphate (GppNHp) were purchased This article has not been copyedited and formatted. The final version may differ from this version. Placid, NY). Antigen was visualized using TMB Stabilized Substrate for HRP (Promega Corp.).
Microscopy.
Laser scanning two-photon imaging was performed using a Zeiss 510 META/NLO attached to an upright Zeiss Axioplan 2 microscope with a 20x, 0.5 NA water-immersion objective (Carl Zeiss AG, Jena, Germany). Fluorescent neurons were excited in two-photon mode with a Chameleon® Ti:Sapphire laser (Coherent Inc., Santa Clara, CA) mode-locked at 850 nm. Emitted photons were filtered with a 500-550 nm bandpass filter and detected on a micro-channel plate photomultiplier (Hamamatsu R3809U-52). The z-axis optical section depth was estimated to be 3.3 µm.
Results
Phosducin expression did not alter maximal Ca 2+ current inhibition in SCG neurons. SCG neurons express α 2 -adrenergic receptors (Schofield, 1991) channel current (hereafter, I Ca ) was evoked every 10 s with the voltage protocol illustrated in Figure 1A (top). The protocol, evoked from a holding potential of -80 mV, consisted of a 25 ms test pulse (denoted prepulse) to +10 mV, a 40 ms conditioning depolarizing step to +80 mV, a 10 ms return to -80 mV, and a second 25 ms test pulse (denoted postpulse) to +10 mV (Elmslie et al., 1990) . Representative I Ca traces recorded in the absence (con) or presence of norepinephrine are illustrated in Figure 1A . In control neurons, the mean amplitudes of the prepulse and postpulse current, measured isochronally 10 ms following the start of the test pulse, were -1.62 ± 0.14 and -2.07 ± 0.17 nA (n=41), respectively. The ratio of the postpulse to prepulse current amplitude in the absence of agonist (termed the basal facilitation ratio) averaged 1.30 ± 0.02 and 1.33 ± 0.04 in uninjected and EGFP-N1 (n=10) expressing neurons (summarized in Fig 1D) . The enhancement of postpulse current amplitude (i.e., facilitation ratio > 1) in the absence of agonist has been shown to arise from tonic Gβγ modulation of N-type Ca 2+ channels in SCG neurons (Ikeda, 1991; Garcia et al., 1998) .
Application of norepinephrine (10 µM) to uninjected neurons decreased the prepulse I Ca by 63.4 ± 1.6% (n=41) and slowed the activation phase of the current (Fig. 1A , E). Conversely, the postpulse I Ca was inhibited by only 26.2 ± 1.1% and the activation phase remained rapid ( Fig   1A) . Similar results were obtained from neurons expressing EGFP alone (prepulse and postpulse I Ca inhibitions of 62.8 ± 3.1 and 24.3 ± 3.4% (n=10), respectively). To determine the effects of expressing PDC on N-type Ca 2+ channel modulation, a cDNA construct consisting of the PDC ORF was cloned into the mammalian expression vector pCI. PDC cDNA was injected into the nuclei of SCG neurons at concentrations ranging from 10-100 ng/µl. In 23 neurons co-injected with EGFP and PDC cDNA, application of 10 µM norepinephrine decreased the pre-and postpulse I Ca by 56.8 ± 3.3 and 24.1 ± 2.1%, respectively-values similar to control ( Fig 1E) . To
This article has not been copyedited and formatted. The final version may differ from this version. ensure that PDC expression was occurring, the ORF of PDC was fused in-frame with EGFP and constructs injected as above. Fusion of EGFP to either termini of PDC results in small but significant decrease in channel modulation. Application of 10 µM norepinephrine to EGFP-PDC or PDC-EGFP expressing neurons (10-100 ng/µL) resulted in 54.2 ± 3.5 and 54.3 ± 2.8% inhibition of prepulse I Ca , respectively (Fig. 1C, E) .
Expression of Gβγ binding proteins has been shown to reduce the N-type Ca 2+ current facilitation ratio in the absence of agonist. For example, expression of Gα subunits (Ikeda, 1996; Jeong and Ikeda, 1999) or a myristoylated C-terminal constructs of G-protein coupled receptor kinase 2 (MAS-GRK2, Kammermeier and Ikeda, 1999) reduce the basal facilitation ratio. In neurons injected with 10-100 ng/µl of PDC cDNA, the mean basal facilitation ratio was 1.19 ± 0.03-a value significantly different from control neurons (Fig. 1D , one-way ANOVA, Dunnett's test). Similarly, expression of the EGFP fusion constructs reduced the basal facilitation ratio (summarized in Fig 1D) .
In contrast, manipulations that increase free Gβγ result in a greater facilitation ratio. For example, activation of adrenergic receptors by agonists increases the ratio of post-to preconditioning pulse current amplitude. This maximal or agonist-induced facilitation ratio determined in the presence of 10 µM norepinephrine was decreased by PDC expression (summarized in Fig 1F) . The peak facilitation ratio increased to 2.74 ± 0.09 and 2.78 ± 0.12 in uninjected and EGFP-expressing cells, respectively, in the presence of agonist. These values averaged 2.32 ± 0.12, 2.22 ± 0.16, and 2.18 ± 0.11 in the PDC, EGFP-PDC and PDC-EGFP injection conditions, respectively. The relief of block following a strong depolarization (resulting in an increased facilitation ratio) and the slowed current activation time course are characteristic features of Gβγ-mediated voltage-dependent inhibition of Ca 2+ channels (reviewed by Jarvis and This article has not been copyedited and formatted. The final version may differ from this version. Figure 2B ). At the fifth minute of drug application, the inhibition of I Ca averaged 28.4 ± 3.4, 17.7 ± 3.1, and 23.2 ± 2.5%, in neurons injected with PDC (n=22), EGFP-PDC (n=20) and PDC-EGFP (n=25), respectively (summarized in Fig. 2C ). In control neurons, the mean agonist facilitation ratio at the end of norepinephrine exposure was 1.99 ± 0.06 and 1.98 ± 0.08 in EGFP injected cells. The agonist facilitation ratio after 5-minute agonist exposure averaged 1.52 ± 0.07, 1.34 ± 0.06 and 1.40 ± 0.04 in PDC (n=22), EGFP-PDC (n=20), and PDC-EGFP (n=25) expressing neurons (summarized in Fig. 2D ). The decrease in agonist facilitation ratio during agonist application indicates a fading of the Gβγ-mediated I Ca inhibition process in PDC expressing neurons. Consistent with this, the prepulse current activated more rapidly in neurons expressing PDC at the end of the agonist application (data not shown).
Expression of phosducin suppressed Ca 2+ channel recovery from inhibition following agonist treatment. It has been hypothesized that phosducin decreases the affinity of free Gβγ This article has not been copyedited and formatted. The final version may differ from this version. subunits with the plasma membrane thereby causing the heterodimer to dissociate from the plasma membrane (Lukov et al., 2004) . If these events occur, then voltage-dependent inhibition of Ca 2+ channels would be expected to diminish upon re-application of agonist. To probe this question, SCG neurons were exposed to norepinephrine for 5 minutes, washed with agonist free solution for 3 minutes, and then re-challenged with norepinephrine (Fig. 2E) . During the second agonist application, the mean peak inhibition was 55.6 ± 1.9% in control cells (n=21) (Fig. 2F ).
Phosducin-like protein affects N-type Ca 2+ channel modulation mediated by α 2 -adrenoceptors. PDCL is ~65% homologous with PDC and binds the Gβγ heterodimer in vitro (Schroder et al., 1996) . However, unlike PDC, PDCL has a more widespread expression pattern thus making it a candidate for modulating GPCR signaling in neurons. At present, it is unclear whether PDCL impacts GPCR mediated inhibition of I Ca . Therefore, SCG neurons were injected with PDCL cDNA and N-type Ca 2+ channel modulation was tested. Following expression of PDCL, peak I Ca inhibition was unaffected. In neurons injected with 10-50 ng/µl pCI-PDCL cDNA, the mean prepulse inhibition was 51.7 ± 3.1% (n=16, example in Fig. 3B ) vs. 55.1 ± 2.5% (n=32) for control neurons (Fig. 3A, D) . The mean peak facilitation ratio during agonist application was also not altered by PDCL expression (2.28 ± 0.10 vs. 2.00 ± 0.13 for control and PDCL-expressing neurons, respectively, ANOVA, p > 0.05). In contrast, the mean basal This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 3C) . In control neurons, the mean basal facilitation ratio was 1.21 ± 0.02 while in PDCL injected neurons this value decreased to 1.12 ± 0.02 (p < 0.05, ANOVA). As with expression of PDC, PDCL caused a more rapid disinhibition of I Ca in the continued presence of agonist (Fig. 3B) . Following 5 minutes of exposure to 10 µM norepinephrine, the peak prepulse inhibition averaged 31.5 ± 2.2% (n=24) in control cells while in those neurons expressing PDCL, peak inhibition averaged 22.1 ± 2.7%
(n=13, Fig. 3E ). The corresponding mean facilitation ratio at the end of the drug application University, Provo, UT) and have been previously characterized (Thulin et al., 1999) . In HEK-293 cells transfected with PDC cDNA, the anti-PDC antibody recognized a protein with an apparent molecular weight of ~31 kDa (Fig. 4A, lane 3) , consistent with the expected size of the PDC protein (Thulin et al., 1999 ). An immunoreactive band corresponding to PDC was not This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 4A, lanes 1-2) . As a test for antibody specificity, HEK-293 cells were transfected with a plasmid encoding PDCL. The anti-PDC antibody weakly detected a protein with an apparent molecular weight of ~42 kDa probably corresponding to overexpression of PDCL (Fig. 4A, lane 4) . This weak cross-reactivity of anti-PDC for PDCL is in agreement with the previous characterization of the antibody (Thulin et al., 1999) . Similar experiments performed on protein prepared from SCG neurons using an anti-PDCL antibody revealed two immunoreactive bands with apparent molecular weights of ~42 and ~40 kDa ( Figure 4C ). Upon expression of PDCL-EGFP protein, green fluorescence was observed within the cytoplasm but restricted from the nucleus in both SCG neurons (Fig 4D) and HEK-293 cells (data not shown). The amplitude of I Ca recorded from uninjected neurons were minimally affected by application of 100 µM L-glutamate (2.9 ± 1.1% inhibition, n=11) supporting previous studies showing that SCG neurons do not express functional mGlu receptors. Prior to agonist application, the basal facilitation ratio averaged 1.14 ± 0.02, 1.03 ± 0.02 and 1.12 ± 0.03 in mGlu 2 (n=14), mGlu 2 /PDC (n=10) and mGlu 2 /PDCL (n=13) conditions, respectively (mGlu 2 /PDC statistically different at p < 0.01 from both mGlu 2 and mGlu 2 /PDCL, ANOVA with Dunnett's post hoc test). Following application of 100 µM L-glutamate to neurons previously injected with pCI-mGlu 2 cDNA (50 ng/µl), prepulse I Ca was inhibited by 64.5 ± 2.8% (n=14; Fig.   5A ). In the continued presence of L-glutamate for 5 minutes, I Ca inhibition decreased to 41.2 ± 1.9%; a result similar to that seen with endogenous α 2 -adrenoceptor activation. PDC or PDCL cDNA (25-50 ng/µl) was co-injected with the mGlu 2 cDNA and EGFP. When mGlu 2 and PDC This article has not been copyedited and formatted. The final version may differ from this version. were co-expressed, the mean peak prepulse inhibition was 61.1 ± 2.5% (n=10) and decreased to 22.7 ± 3.6% in the continued presence of L-glutamate for 5 minutes (Fig 5D, E) . When mGlu 2 and PDCL were co-expressed, peak I Ca inhibition averaged 51.4 ± 3.1% (n=13) and decreased to 17.0 ± 3.1% by the fifth minute of agonist exposure (Fig. 5D, E) . The decrease in the peak inhibition was significantly different when comparing mGlu 2 alone expressing neurons with mGlu 2 /PDCL expressing neurons (ANOVA, Dunnett's test p < 0.05, Fig 5D) . The corresponding facilitation ratios at the end of the L-glutamate application averaged 1.62 ± 0.04, 1.20 ± 0.05 and 1.24 ± 0.04 in the mGlu 2 , mGlu 2 /PDC and mGlu 2 /PDCL conditions, respectively (ANOVA, Dunnett's test, p < 0.001 for both experimental conditions).
Phosducin and phosducin like-protein expression disinhibited voltage-dependent

Phosducin and phosducin like-protein delay voltage dependent inhibition mediated by direct G-protein activation.
The accelerated disinhibition kinetics shown above could result from PDC or PDCL acting directly on the receptor, e.g. desensitization, or coupling to the Gprotein.
To examine this possibility, GppNHp, a non-hydrolyzable analog of GTP, was included in the patch pipette solution thereby bypassing receptor activation as the initiator of modulation.
Because GppNHp traps the Gα subunit in an activated state, Gβγ subunits are free to interact with effectors such as Ca 2+ channels. The normal internal solution containing 300 µM GTP did not alter the pre or post conditioned Ca 2+ current amplitude over 8-10 minutes of recording (data not shown). Conversely, inclusion of GppNHp (500 µM) in the patch pipette resulted in a decrease in I Ca amplitude, slowing of current activation, and increase in facilitation ratio within minutes of patch rupture (Fig. 6 ). Shown in Figure 6A Although it is unclear whether the classical view of Gα-GTP and Gβγ dissociating into "free" subunits is correct (Bünemann et al., 2003) , there is general agreement that activation of heterotrimeric G-proteins involves both conformational changes resulting from GTP binding to Gβγ-binding protein that bound to regions of Gβγ exposed upon receptor activation could detect activation of a wide variety of GPCRs.
Of the Gβγ-binding proteins for which a high resolution structures are available (PDC, Gα, and GRK2), PDC was attractive for several reasons. First, PDC consists of two independent domains (Savage et al., 2000) that bind to distinct surfaces of Gβ (Gaudet et al., 1996 (Gaudet et al., , 1999 Loew et al., 1996) . The PDC N-terminus interacts with the top of the Gβ propeller sharing many residues normally masked by Gα-GDP in the heterotrimeric state. The C-terminus of PDC resembles a thioredoxin domain and interacts with residues on the side of the Gβ propeller distinct from any of those utilized by Gα-GDP. The two-domain structure would facilitate two common strategies used to develop protein-based optical sensors: fluorescence resonance energy transfer (FRET; see review by Miyawaki, 2003) and protein complementation (Hu and Kerpolla, 2003) . Both strategies rely on bringing separate protein moieties (two different fluorescent proteins or two halves of the same fluorescent protein, respectively) into close proximity upon target binding. Knowledge of the PDC-Gβγ structure provides a rational basis for engineering a sensor using techniques such as circular permutation (Nagai et al., 2001) to optimize the proximity of fluorophores or protein domains upon PDC binding to Gβγ. Second, PDC, although interacting natively only with tranducin Gβ 1 γ 1 , binds to numerous different Gβγ combinations in vitro (Müller et al., 1996) suggesting the ability to modify activation by numerous G-protein families. Third, the affinity of PDC and PDCL for Gβγ is altered by phosphorylation of identified residues (Gaudet et al., 1999; Thulin et al., 2001; Humrich et al., 2003) thus providing a rational basis for fine-tuning the interaction.
To evaluate how heterologous expression of PDC and PDCL impacted GPCR function in neurons, N-type Ca 2+ channel function in sympathetic neurons was examined. In this system, This article has not been copyedited and formatted. The final version may differ from this version. voltage-dependent Ca 2+ channel modulation via Gβγ following GPCR activation has been well characterized (e.g., Ikeda, 1996) and the effects of Gα-GDP and the carboxyl-terminus of GRK2 (ctGRK2), two other Gβγ-binding proteins, documented (Jeong and Ikeda, 1999; Kammermeier and Ikeda, 1999) . The finding that PDC and PDCL had little effect on basal facilitation (an indicator of tonic Gβγ-mediated Ca 2+ channel inhibition) or maximal voltage-dependent inhibition of N-type Ca 2+ channels (Fig. 1) was unexpected as heterologous expression of Gαs and ctGRK2 greatly attenuated peak inhibition. A possible explanation for this difference is that PDC and PDCL are cytosolic proteins whereas the latter molecules were targeted to the plasma membrane (the ctGRK used previously was targeted to the membrane via an N-terminal myristolyation sequence; Kammermeier and Ikeda, 1999) . In support of this idea, Rishal et al. (2005) found that targeting PDC to the membrane (via a myristoylation sequence) increased the ability of PDC to modify basal and GPCR-activated GIRK-type K + channels in Xenopus ooctyes.
Preliminary data from our laboratory using analogous constructs resulted in similar augmented effects on Ca 2+ channels in sympathetic neurons (unpublished observation). Prolonged application of agonist indicate that PDC and PDCL function like other Gβγ buffers but require more time before substantial effects are realized (Figs. 2, 3) . Schulz et al. (1998) PDCL, but not PDC, forming a complex with sufficient mass to be excluded from the nucleus. In regard to this observation, PDCL (but not PDC) was recently shown to complex with a chaperone, TCP1α, which regulates the assembly of the Gβγ dimer (Lukov et al., 2005; Humrich et al., 2005) . This finding makes PDCL a less desirable candidate for development as an optical sensor.
The generality of PDC and PDCL actions was tested by heterologously expressing a class III GPCR, the mGlu 2 receptor. In general, disinhibition of Ca 2+ channel modulation was similar to that observed with natively expressed class I α 2 -adrenoceptors (Fig. 5 ). This suggests that PDC and PDCL can generally influence GPCR mediated signaling-at least in regard to receptors that preferentially couple to G i/o proteins. It is unclear whether α 2 -adrenoceptors and mGlu 2 receptors couple to distinct Gβγ isoforms. However, these results are consistent with biochemical studies indicating that PDC can bind numerous Gβγ combinations (Müller et al., 1996) . The results of the re-challenging experiments (Fig. 2E, F (Lukov et al., 2004) . Thus the long term effects of PDC and PDCL may utilize such a mechanism to prevent the re-association of Gβγ with Gα although our data do not specifically address this mechanism. The effects of PDC and PDCL on direct activation of G-proteins (Fig. 6 ) rule out receptor desensitization as the sole mechanism for these effects.
A second goal of these studies was to evaluate potential roles for PDCL in modulating Gprotein mediated ion channel modulation. Western blot analysis indicated that PDCL, but not PDC, is expressed in sympathetic ganglia (Fig. 4 ) consistent with the ubiquitous expression pattern of the former and more restricted expression pattern (i.e., retina and pineal) of the latter.
Although the effects of PDCL expression mimicked those of PDC, recent studies indicate the PDCL is involved in the assembly of Gβ with Gγ (Humrich et al., 2005; Knol et al., 2005; Lukov et al., 2005) . Thus, although our results are compatible with PDCL playing an analogous role in neurons to PDC in the retina, it seems likely that PDCL subserves a more restricted role. For example, siRNA directed against PDCL mRNA reduces Gβγ protein expression (Lukov et al., 2005) . Within this context, Gβγ might be expected to be up regulated when PDCL is overexpressed in SCG neurons. However, the decrease in basal facilitation ratio observed following PDCL expression (Fig. 1) suggests this does not occur on the time scale of our experiments (~24 h).
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